Patients equally happy with mono- and combination therapy

Timolol, latanoprost, and the fixed combinations of latanoprost/timolol (Xalcom; Pfizer) and dorzolamide/timolol (Cosopt; Merck) have equal efficacy and tolerability as well as equal levels of patient satisfaction, according to a study published online, ahead of print, by Graefe's Archive for Clinical and Experimental Ophthalmology.

Timolol, latanoprost, and the fixed combinations of latanoprost/timolol (Xalcom; Pfizer) and dorzolamide/timolol (Cosopt; Merck) have equal efficacy and tolerability as well as equal levels of patient satisfaction, according to a study published online, ahead of print, by Graefe's Archive for Clinical and Experimental Ophthalmology.

Henny J. M. Beckers, MD, PhD of the Department of Ophthalmology, Maastricht University Hospital, the Netherlands and colleagues studied subjects (n=3333) at nine hospitals, who completed questionnaires, to monitor and compare frequency and severity of side effects, patient satisfaction and the rate of medication change requests. The questionnaires used in this study were based on the Comparison of Ophthalmic Medications for Tolerability (COMTOL) questionnaire.

On a scale of 0–320, the median side effect score was 58; the rate of medication change requests was 9%. The drugs demonstrated similar levels of tolerability, and 79% of subjects reported that they were satisfied with their medication.

As patient satisfaction and tolerability levels were similar across the range of prescribed medications, the researchers concluded that the levels of treatment discontinuation were low, and did not differ between drugs.

Related Videos
Disrupting the glaucoma treatment paradigm with novel femtosecond laser from ViaLase
2-year data in contralateral eye evaluation gives edge to iStent inject over Hydrus stent
Should endocyclophotocoagulation be considered part of MIGS? Mr Ratnarajan delves in
Investigating the effects of canaloplasty on corneal epithelium
POAG study hope to open a new avenue for therapies that are for helping treat patients that develop primary open angle glaucoma
Gonio-intervention robot-assisted glaucoma surgical procedure offers high precision
Related Content
© 2023 MJH Life Sciences

All rights reserved.